STOCK TITAN

[Form 4] Prestige Consumer Healthcare Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

CH Robinson Worldwide, Inc. (CHRW) – Form 144 filing

An affiliate has filed a Form 144 indicating an intent to sell 6,364 common shares through Fidelity Brokerage Services on or about 08 Aug 2025. At the 08 Aug 2025 reference price implied by the filing, the shares carry an aggregate market value of ≈ $746,123. The proposed sale represents ~0.005% of the company’s 118.1 million shares outstanding. The shares were originally acquired via a stock-option grant dated 05 Feb 2020 and exercised on the same day as the planned sale. No other sales have been reported by this insider in the past three months.

The notice contains no new operational or financial information; it merely satisfies SEC Rule 144 disclosure requirements for potential insider dispositions. Given the small fraction of shares involved, the filing is generally viewed as routine and immaterial to CHRW’s capital structure and near-term trading dynamics.

CH Robinson Worldwide, Inc. (CHRW) – Presentazione del Modulo 144

Un affiliato ha presentato un Modulo 144 indicando l'intenzione di vendere 6.364 azioni ordinarie tramite Fidelity Brokerage Services intorno al 08 agosto 2025. Al prezzo di riferimento del 08 agosto 2025 indicato nella presentazione, le azioni hanno un valore di mercato complessivo di circa 746.123 $. La vendita proposta rappresenta circa lo 0,005% delle 118,1 milioni di azioni in circolazione della società. Le azioni sono state originariamente acquisite tramite un premio di stock option datato 05 febbraio 2020 e esercitate lo stesso giorno della vendita pianificata. Nessun'altra vendita è stata segnalata da questo insider negli ultimi tre mesi.

La comunicazione non contiene nuove informazioni operative o finanziarie; serve solo a soddisfare i requisiti di divulgazione della Regola SEC 144 per potenziali cessioni da parte di insider. Considerata la piccola percentuale di azioni coinvolte, la presentazione è generalmente considerata routine e irrilevante per la struttura del capitale di CHRW e per le dinamiche di trading a breve termine.

CH Robinson Worldwide, Inc. (CHRW) – Presentación del Formulario 144

Un afiliado ha presentado un Formulario 144 indicando la intención de vender 6,364 acciones ordinarias a través de Fidelity Brokerage Services alrededor del 08 de agosto de 2025. Al precio de referencia del 08 de agosto de 2025 implícito en la presentación, las acciones tienen un valor de mercado agregado de aproximadamente 746,123 $. La venta propuesta representa aproximadamente el 0,005% de las 118.1 millones de acciones en circulación de la compañía. Las acciones fueron adquiridas originalmente mediante una concesión de opciones sobre acciones fechada el 05 de febrero de 2020 y ejercidas el mismo día de la venta planificada. No se han reportado otras ventas por parte de este insider en los últimos tres meses.

El aviso no contiene nueva información operativa o financiera; simplemente cumple con los requisitos de divulgación de la Regla 144 de la SEC para posibles disposiciones de insiders. Dada la pequeña fracción de acciones involucradas, la presentación se considera generalmente rutinaria e insignificante para la estructura de capital de CHRW y las dinámicas de negociación a corto plazo.

CH Robinson Worldwide, Inc. (CHRW) – Form 144 제출

한 계열사가 Fidelity Brokerage Services를 통해 6,364주 보통주를 2025년 8월 8일경에 매도할 의도를 나타내는 Form 144를 제출했습니다. 제출서에 명시된 2025년 8월 8일 기준 가격으로 계산한 해당 주식의 총 시장 가치는 약 746,123달러입니다. 제안된 매도는 회사의 총 1억 1,810만 주 중 약 0.005%에 해당합니다. 이 주식은 2020년 2월 5일에 부여된 스톡옵션을 통해 취득되었으며, 계획된 매도 당일에 행사되었습니다. 지난 3개월간 이 내부자는 다른 매도 내역이 보고되지 않았습니다.

이 통지는 새로운 운영 또는 재무 정보를 포함하지 않으며, 단지 SEC 규칙 144에 따른 내부자 처분 가능성에 대한 공시 요건을 충족하기 위한 것입니다. 소량의 주식이 관련되어 있어, 이 제출은 일반적으로 CHRW의 자본 구조나 단기 거래 동향에 중요하지 않고 일상적인 것으로 간주됩니다.

CH Robinson Worldwide, Inc. (CHRW) – Dépôt du formulaire 144

Un affilié a déposé un formulaire 144 indiquant une intention de vendre 6 364 actions ordinaires via Fidelity Brokerage Services aux alentours du 8 août 2025. Au prix de référence du 8 août 2025 indiqué dans le dépôt, les actions représentent une valeur de marché totale d’environ 746 123 $. La vente proposée représente environ 0,005 % des 118,1 millions d’actions en circulation de la société. Les actions ont été initialement acquises via une attribution d’options sur actions datée du 5 février 2020 et exercées le même jour que la vente prévue. Aucune autre vente n’a été signalée par cet initié au cours des trois derniers mois.

L’avis ne contient aucune nouvelle information opérationnelle ou financière ; il se contente de satisfaire aux exigences de divulgation de la règle 144 de la SEC concernant les cessions potentielles d’initiés. Étant donné la faible fraction d’actions concernée, ce dépôt est généralement considéré comme routinier et sans importance pour la structure du capital de CHRW et les dynamiques de négociation à court terme.

CH Robinson Worldwide, Inc. (CHRW) – Einreichung des Formulars 144

Ein verbundenes Unternehmen hat ein Formular 144 eingereicht, das die Absicht zum Verkauf von 6.364 Stammaktien über Fidelity Brokerage Services etwa am 08. August 2025 anzeigt. Zum im Formular angegebenen Referenzpreis vom 08. August 2025 haben die Aktien einen gesamten Marktwert von etwa 746.123 $. Der vorgeschlagene Verkauf entspricht etwa 0,005% der 118,1 Millionen ausstehenden Aktien des Unternehmens. Die Aktien wurden ursprünglich durch eine Aktienoptionszuteilung vom 05. Februar 2020 erworben und am selben Tag wie der geplante Verkauf ausgeübt. In den letzten drei Monaten wurden keine weiteren Verkäufe dieses Insiders gemeldet.

Die Mitteilung enthält keine neuen operativen oder finanziellen Informationen; sie erfüllt lediglich die Offenlegungspflichten gemäß SEC-Regel 144 für potenzielle Insider-Veräußerungen. Angesichts des geringen Anteils der betroffenen Aktien wird die Einreichung allgemein als routine und unerheblich für die Kapitalstruktur von CHRW und die kurzfristigen Handelsdynamiken angesehen.

Positive
  • None.
Negative
  • Insider intends to sell 6,364 shares worth ≈ $746k, which could be perceived as modest profit-taking, though the scale is immaterial.

Insights

TL;DR: Minor insider sale (6.3k shares, <0.01% float); negligible impact on CHRW valuation or liquidity.

The planned disposition totals roughly $0.75 million versus CHRW’s multi-billion-dollar market cap and robust daily trading volume. Such filings are customary clearance notices rather than firm commitments to sell, and the share count is too small to influence market supply. No earnings, guidance, or strategic data are disclosed, so the event does not alter the fundamental outlook. I view the impact on investors as neutral.

TL;DR: Routine Rule 144 compliance; no red flags in insider-trading or disclosure practices.

The filer affirms no undisclosed adverse information, satisfying Rule 144’s good-faith requirement. The absence of clustered insider selling and the modest share count indicate ordinary portfolio management rather than a governance concern. Compliance procedures appear sound, and no additional insider aggregation triggers are noted. Overall governance implications are minimal.

CH Robinson Worldwide, Inc. (CHRW) – Presentazione del Modulo 144

Un affiliato ha presentato un Modulo 144 indicando l'intenzione di vendere 6.364 azioni ordinarie tramite Fidelity Brokerage Services intorno al 08 agosto 2025. Al prezzo di riferimento del 08 agosto 2025 indicato nella presentazione, le azioni hanno un valore di mercato complessivo di circa 746.123 $. La vendita proposta rappresenta circa lo 0,005% delle 118,1 milioni di azioni in circolazione della società. Le azioni sono state originariamente acquisite tramite un premio di stock option datato 05 febbraio 2020 e esercitate lo stesso giorno della vendita pianificata. Nessun'altra vendita è stata segnalata da questo insider negli ultimi tre mesi.

La comunicazione non contiene nuove informazioni operative o finanziarie; serve solo a soddisfare i requisiti di divulgazione della Regola SEC 144 per potenziali cessioni da parte di insider. Considerata la piccola percentuale di azioni coinvolte, la presentazione è generalmente considerata routine e irrilevante per la struttura del capitale di CHRW e per le dinamiche di trading a breve termine.

CH Robinson Worldwide, Inc. (CHRW) – Presentación del Formulario 144

Un afiliado ha presentado un Formulario 144 indicando la intención de vender 6,364 acciones ordinarias a través de Fidelity Brokerage Services alrededor del 08 de agosto de 2025. Al precio de referencia del 08 de agosto de 2025 implícito en la presentación, las acciones tienen un valor de mercado agregado de aproximadamente 746,123 $. La venta propuesta representa aproximadamente el 0,005% de las 118.1 millones de acciones en circulación de la compañía. Las acciones fueron adquiridas originalmente mediante una concesión de opciones sobre acciones fechada el 05 de febrero de 2020 y ejercidas el mismo día de la venta planificada. No se han reportado otras ventas por parte de este insider en los últimos tres meses.

El aviso no contiene nueva información operativa o financiera; simplemente cumple con los requisitos de divulgación de la Regla 144 de la SEC para posibles disposiciones de insiders. Dada la pequeña fracción de acciones involucradas, la presentación se considera generalmente rutinaria e insignificante para la estructura de capital de CHRW y las dinámicas de negociación a corto plazo.

CH Robinson Worldwide, Inc. (CHRW) – Form 144 제출

한 계열사가 Fidelity Brokerage Services를 통해 6,364주 보통주를 2025년 8월 8일경에 매도할 의도를 나타내는 Form 144를 제출했습니다. 제출서에 명시된 2025년 8월 8일 기준 가격으로 계산한 해당 주식의 총 시장 가치는 약 746,123달러입니다. 제안된 매도는 회사의 총 1억 1,810만 주 중 약 0.005%에 해당합니다. 이 주식은 2020년 2월 5일에 부여된 스톡옵션을 통해 취득되었으며, 계획된 매도 당일에 행사되었습니다. 지난 3개월간 이 내부자는 다른 매도 내역이 보고되지 않았습니다.

이 통지는 새로운 운영 또는 재무 정보를 포함하지 않으며, 단지 SEC 규칙 144에 따른 내부자 처분 가능성에 대한 공시 요건을 충족하기 위한 것입니다. 소량의 주식이 관련되어 있어, 이 제출은 일반적으로 CHRW의 자본 구조나 단기 거래 동향에 중요하지 않고 일상적인 것으로 간주됩니다.

CH Robinson Worldwide, Inc. (CHRW) – Dépôt du formulaire 144

Un affilié a déposé un formulaire 144 indiquant une intention de vendre 6 364 actions ordinaires via Fidelity Brokerage Services aux alentours du 8 août 2025. Au prix de référence du 8 août 2025 indiqué dans le dépôt, les actions représentent une valeur de marché totale d’environ 746 123 $. La vente proposée représente environ 0,005 % des 118,1 millions d’actions en circulation de la société. Les actions ont été initialement acquises via une attribution d’options sur actions datée du 5 février 2020 et exercées le même jour que la vente prévue. Aucune autre vente n’a été signalée par cet initié au cours des trois derniers mois.

L’avis ne contient aucune nouvelle information opérationnelle ou financière ; il se contente de satisfaire aux exigences de divulgation de la règle 144 de la SEC concernant les cessions potentielles d’initiés. Étant donné la faible fraction d’actions concernée, ce dépôt est généralement considéré comme routinier et sans importance pour la structure du capital de CHRW et les dynamiques de négociation à court terme.

CH Robinson Worldwide, Inc. (CHRW) – Einreichung des Formulars 144

Ein verbundenes Unternehmen hat ein Formular 144 eingereicht, das die Absicht zum Verkauf von 6.364 Stammaktien über Fidelity Brokerage Services etwa am 08. August 2025 anzeigt. Zum im Formular angegebenen Referenzpreis vom 08. August 2025 haben die Aktien einen gesamten Marktwert von etwa 746.123 $. Der vorgeschlagene Verkauf entspricht etwa 0,005% der 118,1 Millionen ausstehenden Aktien des Unternehmens. Die Aktien wurden ursprünglich durch eine Aktienoptionszuteilung vom 05. Februar 2020 erworben und am selben Tag wie der geplante Verkauf ausgeübt. In den letzten drei Monaten wurden keine weiteren Verkäufe dieses Insiders gemeldet.

Die Mitteilung enthält keine neuen operativen oder finanziellen Informationen; sie erfüllt lediglich die Offenlegungspflichten gemäß SEC-Regel 144 für potenzielle Insider-Veräußerungen. Angesichts des geringen Anteils der betroffenen Aktien wird die Einreichung allgemein als routine und unerheblich für die Kapitalstruktur von CHRW und die kurzfristigen Handelsdynamiken angesehen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hopkins Sheila

(Last) (First) (Middle)
660 WHITE PLAINS ROAD

(Street)
TARRYTOWN NY 10591

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Prestige Consumer Healthcare Inc. [ PBH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.01 per share 08/05/2025 A 2,094(1) A $0 30,123 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The Reporting Person received 2,094 restricted stock units equal to $155,000 divided by the closing stock price of $74.04 on August 5, 2025, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.
/s/ Shelia A. Hopkins by Christine Sacco Attorney-in-Fact pursuant to Power of Attorney Dated May 8, 2017 on file with the Commission 08/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many CHRW shares are being registered for sale under this Form 144?

6,364 common shares are listed for potential sale.

What is the estimated market value of the planned CHRW share sale?

The filing cites an aggregate market value of about $746,123.

When is the approximate sale date for the CHRW shares?

The filer lists 08 Aug 2025 as the intended sale date.

What percentage of CH Robinson’s outstanding shares does the sale represent?

Roughly 0.005% of the 118.1 million shares outstanding.

Does the Form 144 disclose any prior insider sales within the last three months?

No. The section ‘Securities Sold During the Past 3 Months’ states “Nothing to Report.”

How were the shares originally acquired by the insider?

Through an option grant dated 05 Feb 2020, exercised on 08 Aug 2025.
Prestige Consmr Healthcare Inc

NYSE:PBH

PBH Rankings

PBH Latest News

PBH Latest SEC Filings

PBH Stock Data

3.65B
48.61M
1.23%
108.53%
3.08%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
TARRYTOWN